【医伴旅】依维莫司/来曲唑联合疗法提高了晚期乳腺癌患者的生存率
撰稿: 医伴旅内容团队
原创文章,未经许可,请勿转载
商务合作请联系:13304614152
抓紧报名丨添加请备注:00503
参考资料:
Everolimus/Letrozole Provides Survival Benefit in HR-Positive/ERBB2-Negative Advanced Breast Cancer (cancernetwork.com)
赞 (0)
撰稿: 医伴旅内容团队
原创文章,未经许可,请勿转载
商务合作请联系:13304614152
抓紧报名丨添加请备注:00503
参考资料:
Everolimus/Letrozole Provides Survival Benefit in HR-Positive/ERBB2-Negative Advanced Breast Cancer (cancernetwork.com)